Docetaxel: promising and novel combinations in ovarian cancer

por Mäenpää, J U
Publicado 2003

Expression Analysis of Platinum Sensitive and Resistant Epithelial Ovarian Cancer Patient Samples Reveals New Candidates for Targeted Therapies()

por Veskimäe, K, Scaravilli, M, Niininen, W, Karvonen, H, Jaatinen, S, Nykter, M, Visakorpi, T, Mäenpää, J, Ungureanu, D, Staff, S
Publicado 2018

Factors associated with decision-making on prophylactic hysterectomy and attitudes towards gynecological surveillance among women with Lynch syndrome (LS): a descriptive study

por Kalamo, Mari H., Mäenpää, J. U., Seppälä, T. T., Mecklin, J. P., Huhtala, H., Sorvettula, K., Pylvänäinen, K., Staff, S.
Publicado 2020

Neutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy—findings from clinical practice

por Krzemieniecki, K., Sevelda, P., Erdkamp, F., Smakal, M., Schwenkglenks, M., Puertas, J., Trojan, A., Szabo, Z., Bendall, K., Maenpaa, J.
Publicado 2013

Tumor cell-specific Serpin A1 expression in vulvar squamous cell carcinoma

por Lagerstedt, Maria, Huotari-Orava, R., Nyberg, R., Nissinen, L., Farshchian, M., Laasanen, S.-L., Snellman, E., Mäenpää, J. U., Kähäri, V.-M.
Publicado 2019

SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel–irinotecan as first-line therapy for ovarian cancer

por Clamp, A R, Mäenpää, J, Cruickshank, D, Ledermann, J, Wilkinson, P M, Welch, R, Chan, S, Vasey, P, Sorbe, B, Hindley, A, Jayson, G C
Publicado 2006

CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial

por Alexandre, J, Brown, C, Coeffic, D, Raban, N, Pfisterer, J, Mäenpää, J, Chalchal, H, Fitzharris, B, Volgger, B, Vergote, I, Pisano, C, Ferrero, A, Pujade-Lauraine, E
Publicado 2012

Carboplatin–paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer

por Lee, C K, Gurney, H, Brown, C, Sorio, R, Donadello, N, Tulunay, G, Meier, W, Bacon, M, Maenpaa, J, Petru, E, Reed, N, Gebski, V, Pujade-Lauraine, E, Lord, S, Simes, R J, Friedlander, M
Publicado 2011

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/...

por Colombo, N., Gadducci, A., Sehouli, J., Rulli, E., Mäenpää, J., Sessa, C., Montes, A., Ottevanger, N. B., Berger, R., Vergote, I., D’Incalci, M., Churruca Galaz, C., Chekerov, R., Nyvang, G. B., Riniker, S., Herbertson, R., Fossati, R., Barretina-Ginesta, M. P., Deryal, M., Mirza, M. R., Biagioli, E., Iglesias, M., Funari, G., Romeo, M., Tasca, G., Pardo, B., Tognon, G., Rubio-Pérez, M. J., DeCensi, A., De Giorgi, U., Zola, P., Benedetti Panici, P., Aglietta, M., Arcangeli, V., Zamagni, C., Bologna, A., Westermann, A., Heinzelmann-Schwarz, V., Tsibulak, I., Wimberger, P., Poveda, A.
Publicado 2023